MedPath

Clinico-demographic Features of Patients With Acne Vulgaris

Conditions
Acne Vulgaris
Registration Number
NCT05061615
Lead Sponsor
Sohag University
Brief Summary

The Global Burden of Disease Study 2010 found that acne vulgaris is the eight most common skin disease, with an estimated global prevalence (for all ages) of 9.38%.(1) Furthermore . Acne is a chronic inflammatory process that presents with two types of lesions clinically; non-inflammatory (closed and open) and inflammatory lesions (papules ,pustules ,nodules and post inflammatory pigmentary changes).

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
150
Inclusion Criteria
  • patients of both sexes with clinical evident acne vulgaris
  • any age
Exclusion Criteria
  • no exclusion criteria

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Body mass indexone year

(weight (kg)/height(m)2)

severity of acne vulgarisOne year

Global acne grading system (GAGS):

The GAGS is an acne grading system developed by Doshi et al . (13) In this grading system, lesions of acne vulgaris are divided into six sites: the forehead, right cheek, left cheek, nose, chin, and chest back.Each site has one factor score: the chin and nose are graded by one factor, the forehead and each cheek are graded by two factors and the chest and back are graded by three factors. Lesions are scored as follows: one point for a comedone, two points for a papule, three points for a pustule, and four points for a nodule. The lesion score of each site is calculated by the factor score, and the final score for that site is obtained. The total score varies between 1 and 44 and is evaluated as follows: mild falls between 1 and 18, moderate falls between 19 and 30, severe falls between 31 and 38, and very severe is over 39.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sohag University Hospital

🇪🇬

Sohag, Egypt

© Copyright 2025. All Rights Reserved by MedPath